Clearmind Medicine Inc.

NASDAQ: CMND · Real-Time Price · USD
1.03
0.03 (3.00%)
At close: Aug 22, 2025, 3:58 PM
1.00
-2.91%
After-hours: Aug 22, 2025, 04:58 PM EDT

Clearmind Medicine Cash Flow Statement

Financials in USD. Fiscal year is November - October.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Oct 31, 2024 Oct 31, 2023 Oct 31, 2022 Oct 31, 2021
Net Income
-5.25M -6.23M -6.89M -2.73M
Depreciation & Amortization
51.07K 41.59K 83.07K 2.57K
Stock-Based Compensation
883.87K 366.4K 1.65K 619.94K
Other Working Capital
-195.06K -253.22K 441.42K -317.61K
Other Non-Cash Items
-512.7K 210.72K -2.15K -758.24K
Deferred Income Tax
103.88K 17.37K 40.75K n/a
Change in Working Capital
-130.11K -703.89K 1.69M 25.99K
Operating Cash Flow
-4.86M -6.3M -5.08M -2.84M
Capital Expenditures
n/a n/a -7.59K -231.19K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-350.4K n/a n/a -20K
Sales Maturities Of Investments
78.5K n/a n/a n/a
Other Investing Acitivies
33.8K -26.23K -7.58K n/a
Investing Cash Flow
-238.1K -26.23K -7.59K -251.19K
Debt Repayment
-42.59K -40.92K -96.54 n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
4.1M 3.67M 115.94K 3.01M
Financial Cash Flow
6.25M 11.66M 698.4K 7.36M
Net Cash Flow
1.15M 5.3M -4.42M 4.29M
Free Cash Flow
-4.86M -6.3M -5.09M -3.07M